Optimark and Aspirin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Optimark (gadoversetamide) and Aspirin (aspirin). Common drug interactions include pain among females and nephrogenic systemic fibrosis among males.
The phase IV clinical study analyzes what interactions people have when they take Optimark and Aspirin. It is created by eHealthMe based on reports of 318 people who take the same drugs from the FDA, and is updated regularly.
What is Optimark?
Optimark has active ingredients of gadoversetamide. eHealthMe is studying from 3,055 Optimark users. Check the latest studies of Optimark.
What is Aspirin?
Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 632,089 Aspirin users. Check the latest studies of Aspirin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
318 people who take Optimark and Aspirin together, and have interactions are studied.
What are the common drug interactions of Optimark and Aspirin, by gender? *
What are the common drug interactions of Optimark and Aspirin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Optimark and Aspirin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Optimark and Aspirin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Optimark:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Aspirin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Optimark and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aspirin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on gadoversetamide and aspirin (the active ingredients of Optimark and Aspirin, respectively), and Optimark and Aspirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Optimark and Aspirin - 5 seconds ago
- Could Glipizide cause Pyogenic Liver Abscess? - 6 seconds ago
- Could Proair Hfa cause General Physical Health Deterioration? - 15 seconds ago
- Restless Leg Syndrome and Hallucinations - 26 seconds ago
- Could Depakote cause Enteritis? - 27 seconds ago
- Could Hydroxychloroquine Sulfate cause Rib Fracture? - 35 seconds ago
- Could Prograf cause Placental Insufficiency? - 38 seconds ago
- Could Valium cause Placenta Abruptio? - 40 seconds ago
- Could Cefazolin Sodium cause Constipation? - 48 seconds ago
- Psoriatic Arthropathy and Fungal Oesophagitis - 50 seconds ago